|
1
|
Network GA: The global asthma report 2014.
(Auckland, New Zealand). Global Asthma Network, 2014.
2017.PubMed/NCBI
|
|
2
|
Murray CJ, Vos T, Lozano R, Naghavi M,
Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdallah S,
et al: Disability-adjusted life years (DALYs) for 291 diseases and
injuries in 21 regions, 1990–2010: A systematic analysis for the
Global Burden of disease study 2010. Lancet. 380:2197–2223. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
To T, Stanojevic S, Moores G, Gershon AS,
Bateman ED, Cruz AA and Boulet LP: Global asthma prevalence in
adults: Findings from the cross-sectional world health survey. BMC
Public Health. 12:2042012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Steinke JW and Borish L: Th2 cytokines and
asthma. Interleukin-4: Its role in the pathogenesis of asthma, and
targeting it for asthma treatment with interleukin-4 receptor
antagonists. Respi Res. 2:66–70. 2001. View
Article : Google Scholar
|
|
5
|
Anto JM, Bousquet J, Akdis M, Auffray C,
Keil T, Momas I, Postma DS, Valenta R, Wickman M, Cambon-Thomsen A,
et al: Mechanisms of the development of allergy (MeDALL):
Introducing novel concepts in allergy phenotypes. J Allergy Clin
Immunol. 139:388–399. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fajt ML and Wenzel SE: Development of new
therapies for severe asthma. Allergy Asthma Immunol Res. 9:3–14.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kaur J, Alvarez A, Hanna HW, Krishnan AC,
Senador D, Machado TM, Altamimi YH, Lovelace AT, Dombrowski MD,
Spranger MD, et al: Interaction between the muscle metaboreflex and
the arterial baroreflex in control of arterial pressure and
skeletal muscle blood flow. Am J Physiol Heart Circ Physiol.
311:H1268–H1276. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Newnham JP: Is prenatal glucocorticoid
administration another origin of adult disease? Clin Exp Pharmacol
Physiol. 28:957–961. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Barnes PJ: Reduced histone deacetylase in
COPD: Clinical implications. Chest. 129:151–155. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee SS, Tan NH, Fung SY, Sim SM, Tan CS
and Ng ST: Anti-inflammatory effect of the sclerotium of Lignosus
rhinocerotis (Cooke) Ryvarden, the Tiger Milk mushroom. BMC
Complement and Altern Med. 14:3592014. View Article : Google Scholar
|
|
11
|
Yap YH, Tan N, Fung S, Aziz AA, Tan C and
Ng S: Nutrient composition, antioxidant properties, and
anti-proliferative activity of Lignosus rhinocerus Cooke
sclerotium. J Sci Food Agric. 93:2945–2952. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wong KH, Lai CK and Cheung PC:
Immunomodulatory activities of mushroom sclerotial polysaccharides.
Food Hydrocol. 25:150–158. 2011. View Article : Google Scholar
|
|
13
|
Johnathan M, Gan SH, Ezumi MF, Faezahtul
AH and Nurul AA: Phytochemical profiles and inhibitory effects of
Tiger Milk mushroom (Lignosus rhinocerus) extract on
ovalbumin-induced airway inflammation in a rodent model of asthma.
BMC Complement Altern Med. 16:1672016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jonathan G, Loveth K and Elijah O:
Antagonistic effect of extracts of some Nigerian higher fungi
against selected pathogenic microorganisms. Am Eur J Agric Environ
Sci. 2:364–368. 2007.
|
|
15
|
Jeon WY, Shin IS, Shin HK, Jin SE and Lee
MY: Aqueous extract of gumiganghwal-tang, a traditional herbal
medicine, reduces pulmonary fibrosis by transforming growth
Factor-β1/Smad signaling pathway in murine model of chronic Asthma.
PLoS One. 11:e01648332016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Myou S, Leff AR, Myo S, Boetticher E, Tong
J, Meliton AY, Liu J, Munoz NM and Zhu X: Blockade of inflammation
and airway hyperresponsiveness in immune-sensitized mice by
dominant-negative phosphoinositide 3-kinase-TAT. J Exp Med.
198:1573–1582. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee MY, Ahn KS, Kwon OK, Kim MJ, Kim MK,
Lee IY, Oh SR and Lee HK: Anti-inflammatory and anti-allergic
effects of kefir in a mouse asthma model. Immunobiol. 212:647–654.
2007. View Article : Google Scholar
|
|
18
|
Prado CM, Leick-Maldonado EA, Kasahara DI,
Capelozzi VL, Martins MA and Tibério IF: Effects of acute and
chronic nitric oxide inhibition in an experimental model of chronic
pulmonary allergic inflammation in guinea pigs. American Am J
Physiol Lung Cell Mol Physiol. 289:L677–L683. 2005. View Article : Google Scholar
|
|
19
|
Kumar RK, Herbert C and Foster PS: The
‘classical’ ovalbumin challenge model of asthma in mice. Curr Drug
Targets. 9:485–494. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kang JH, Kim BS, Uhm TG, Lee SH, Lee GR,
Park CS and Chung IY: Gamma-secretase inhibitor reduces allergic
pulmonary inflammation by modulating Th1 and Th2 responses. Am J
Respi Critical Care Med. 179:875–882. 2009. View Article : Google Scholar
|
|
21
|
Zhou M, Cui ZL, Guo XJ, Ren LP, Yang M,
Fan ZW, Han RC and Xu WG: Blockade of Notch signalling by
γ-secretase inhibitor in lung T cells of asthmatic mice affects T
cell differentiation and pulmonary inflammation. Inflammation.
38:1281–1288. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shin YS, Takeda K and Gelfand EW:
Understanding asthma using animal models. Allergy Asthma Immunol
Res. 1:10–18. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Trifilieff A, El-Hashim A and Bertrand C:
Time course of inflammatory and remodeling events in a murine model
of asthma: Effect of steroid treatment. Am J Physiol Lung Cell Mol
Physiol. 279:L1120–L1128. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bosire EM, Nyamache AK, Gicheru MM,
Khamadi SA, Lihana RW and Okoth V: Population specific reference
ranges of CD3, CD4 and CD8 lymphocyte subsets among healthy
Kenyans. AIDS Res Ther. 10:242013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Larché M, Robinson DS and Kay AB: The role
of T lymphocytes in the pathogenesis of asthma. J Allergy Clin
Immunol. 111:450–464. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Barnes PJ: Immunology of asthma and
chronic obstructive pulmonary disease. Nat Rev Immunol. 8:183–192.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Massoud AH, Charbonnier LM, Lopez D,
Pellegrini M, Phipatanakul W and Chatila TA: An asthma-associated
IL4R variant exacerbates airway inflammation by promoting
conversion of regulatory T cells to TH17-like cells. Nat Med.
22:1013–1022. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tao B, Ruan G, Wang D, Li Y, Wang Z and
Yin G: Imbalance of peripheral Th17 and regulatory T cells in
children with allergic rhinitis AND bronchial asthma. Iran J
Allergy Asthma Immunol. 14:273–279. 2015.PubMed/NCBI
|
|
29
|
Tian M, Wang Y, Lu Y, Jiang YH and Zhao
DY: Effects of sublingual immunotherapy for dermatophagoides
farinae on Th17 cells and CD4(+) CD25(+) regulatory T cells in
peripheral blood of children with allergic asthma. Int Forum
Allergy Rhinol. 4:371–375. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ma C, Ma Z, Fu Q and Ma S: Curcumin
attenuates allergic airway inflammation by regulation of CD4+ CD25+
regulatory T cells (Tregs)/Th17 balance in ovalbumin-sensitized
mice. Fitoter. 87:57–64. 2013. View Article : Google Scholar
|
|
31
|
Boyce JA and Austen KF: No audible
wheezing: Nuggets and conundrums from mouse asthma models. J Exp
Med. 201:1869–1873. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nials AT and Uddin S: Mouse models of
allergic asthma: Acute and chronic allergen challenge. Dis Models
Mech. 1:213–220. 2008. View Article : Google Scholar
|
|
33
|
Ming M, Luo Z, Lv S, Sun Q and Li C:
Inactivated Mycobacterium phlei inhalation ameliorates allergic
asthma through modulating the balance of CD4+CD25+ regulatory T and
Th17 cells in mice. Iran J Basic Med Sci. 19:953–959.
2016.PubMed/NCBI
|
|
34
|
Deckers J, Branco Madeira F and Hammad H:
Innate immune cells in asthma. Trends Immunol. 34:540–547. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Stone KD, Prussin C and Metcalfe DD: IgE,
mast cells, basophils, and eosinophils. J Allergy Clin Immunol. 125
(2 Suppl 2):S73–S80. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bandeira-Melo C, Bozza PT and Weller PF:
The cellular biology of eosinophil eicosanoid formation and
function. J Allergy Clin Immunol. 109:393–400. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Monteseirín J: Neutrophils and asthma. J
Investig Allergol Clin Immunol. 19:340–354. 2009.PubMed/NCBI
|
|
38
|
Nabe T, Hosokawa F, Matsuya K, Morishita
T, Ikedo A, Fujii M, Mizutani N, Yoshino S and Chaplin DD:
Important role of neutrophils in the late asthmatic response in
mice. Life Sci. 88:1127–1135. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Busse WW and Lemanske RF Jr: Asthma. New
Eng J Med. 344:350–362. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hwang SS, Kim YU, Lee S, Jang SW, Kim MK,
Koh BH, Lee W, Kim J, Souabni A, Busslinger M and Lee GR:
Transcription factor YY1 is essential for regulation of the Th2
cytokine locus and for Th2 cell differentiation. Proc Natl Acad Sci
USA. 110:276–281. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lambrecht BN and Hammad H: The immunology
of asthma. Nat Immunol. 16:45–56. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wills-Karp M: Interleukin-13 in asthma
pathogenesis. Immunol Rev. 202:175–190. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Brightling C, Saha S and Hollins F:
Interleukin-13: Prospects for new treatments. Clin Exp Allergy.
40:42–49. 2010.PubMed/NCBI
|
|
44
|
Desai D and Brightling C: Cytokine and
anti-cytokine therapy in asthma: Ready for the clinic? Clin Exp
Immunol. 158:10–19. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Fatemi F, Sadroddiny E, Gheibi A,
Mohammadi Farsani T and Kardar GA: Biomolecular markers in
assessment and treatment of asthma. Respirology. 19:514–523. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Holgate ST: Innate and adaptive immune
responses in asthma. Nat Med. 18:673–683. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gould HJ and Sutton BJ: IgE in allergy and
asthma today. Nat Rev Immunol. 8:205–217. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Barnes PJ: The cytokine network in asthma
and chronic obstructive pulmonary disease. J Clin Invest.
118:3546–3556. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Galli SJ, Grimbaldeston M and Tsai M:
Immunomodulatory mast cells: Negative, as well as positive,
regulators of immunity. Nat Rev Immunol. 8:478–486. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Curtis JL, Warnock ML, Arraj SM and
Kaltreider HB: Histologic analysis of an immune response in the
lung parenchyma of mice. Angiopathy accompanies inflammatory cell
influx. Am J Pathol. 137:689–699. 1990.PubMed/NCBI
|
|
51
|
Jin H, Luo Q, Zheng Y, Nurahmat M, Wu J,
Li B, Lv Y, Wang G, Duan X and Dong J: CD4+CD25+Foxp3+ T cells
contribute to the antiasthmatic effects of Astragalus membranaceus
extract in a rat model of asthma. Int Immunopharmacol. 15:42–49.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Amorim J, de Calvalho Borges M, Fabro AT,
Contini SHT, Valdevite M, Pereira AMS and Carmona F: The ethanolic
extract from Erythrina mulungu Benth. flowers attenuates
allergic airway inflammation and hyperresponsiveness in a murine
model of asthma. J Ethnopharmacol. Aug 10–2018.(Epub ahead of
print). View Article : Google Scholar
|
|
53
|
Kraft M: The distal airways: Are they
important in asthma? Eur Respir J. 14:1403–1417. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kraft M, Martin RJ, Wilson S, Djukanovic R
and Holgate ST: Lymphocyte and eosinophil influx into alveolar
tissue in nocturnal asthma. Am J Respir Crit Care Med. 159:228–234.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Kelly EA, Houtman JJ and Jarjour NN:
Inflammatory changes associated with circadian variation in
pulmonary function in subjects with mild asthma. Clin Exp Allergy.
34:227–233. 2004. View Article : Google Scholar : PubMed/NCBI
|
